MiniMed Group, Inc. (NASDAQ:MMED)
| Market Cap | $4.50B-13.4% |
| Revenue (ttm) | $3.22B |
| Net Income | -$329.00M |
| EPS | -$1.20 |
| Shares Out | 281.35M |
| PE Ratio | n/a |
| Forward PE | 21.84 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,573,375 |
| Open | $16.08 |
| Previous Close | $16.26 |
| Day's Range | $15.92 - $16.79 |
| 52-Week Range | $10.65 - $24.43 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | $25.73(+60.71%) |
| Earnings Date | Dec 30, 2026 |
About MMED
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Analyst consensus
8 firms rating MMED in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Dec 30, 2026Earnings report
$MMED stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in MMED holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MMED's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MMED Estimated quarterly lobbying spending
Source: U.S. Senate LDA
MMED Revenue by Segment or Geography
| CGM | $431.00M | 51.13% |
| Consumables | $261.00M | 30.96% |
| Pumps | $144.00M | 17.08% |
| Other | $7.00M | 0.83% |
As of: Q3 2026 (Jul 31, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New MMED patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MMED from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MMED
| VTIVanguard Morningstar Total Stock Market ETF | $129.53M |
| IWMiShares Russell 2000 ETF | $122.94M |
| VBVanguard Morningstar Small-Cap ETF | $115.34M |
| VBRVanguard Morningstar Small-Cap Value ETF | $74.95M |
| VXFVanguard Extended Market ETF | $58.27M |
| IWNiShares Russell 2000 Value ETF | $44.26M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from MMED’s recent data — informational, not investment advice
What’s Behind the Score
News check: Multiple product launches (MiniMed Flex, MiniMed Fit) with regulatory clearance demonstrate strong pipeline execution and market expansion in diabetes care.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| MGMT | Ballast Small/Mid Cap ETF | 1.76% |
| FPX | First Trust US Equity Opportunities ETF | 1.06% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 0.97% |
| MMID | MFS Active Exchange Traded Funds Trust - MFS Active Mid Cap ETF | 0.95% |
| FSEV | Fidelity Enhanced Small Cap Value ETF | 0.42% |
| IWN | iShares Russell 2000 Value ETF | 0.35% |
| FESM | Fidelity Enhanced Small Cap ETF | 0.30% |
| FSCC | Federated Hermes MDT Small Cap Core ETF | 0.28% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.22% |
| RUSC | Russell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETF | 0.19% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.18% |
| AAEQ | Alpha Architect US Equity 2 ETF | 0.18% |
Weight is the stock’s share of each fund’s holdings.
